FindTrial
Sign In

The prevention and therapeutic effect of Jinghua Weikang capsule on aspirin-related gastrointestinal injury

The prevention and therapeutic effect of Jinghua Weikang capsule on aspirin-related gastrointestinal injury

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014965
Enrollment
Unknown
Registered
2018-02-25
Start date
2016-01-01
Completion date
Unknown
Last updated
2018-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aspirin-related gastrointestinal injury

Interventions

2:teprenone
1:Jinghua Weikang pill

Sponsors

Department of Gastroenterology, China-Japan Union Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged more than 18 years old, male or female; 2. To take or have taken aspirin for more than one month; 3. No capsule endoscopy for contraindications; 4. With the ability of informed consent, we can stick to this study. The visit plan can complete all the research reviews. Estimates.

Exclusion criteria

Exclusion criteria: 1. Have capsule endoscopy for contraindications; 2. Patients with peptic ulcer and complications; 3. History of gastrointestinal bleeding; 4. Glucocorticoids should be taken; 5. Pregnant women and pregnant women; 6. Combining mental illness or severe neurosis, Those who cannot express subjective discomfort; Rejection or unacceptability.

Design outcomes

Primary

MeasureTime frame
Capsule endoscopy score;—

Countries

China

Contacts

Public ContactJiangbn Wang

Department of Gastroenterology, China-Japan Union Hospital of Jilin University

zrlwangjb@medmail.com.cn+86 13578993125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026